Measles cost-effectiveness of therapy

Jump to navigation Jump to search

Measles Microchapters


Patient Information


Historical Perspective



Differentiating Measles from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis


Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies


Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Measles cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Measles cost-effectiveness of therapy

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Measles cost-effectiveness of therapy

CDC on Measles cost-effectiveness of therapy

Measles cost-effectiveness of therapy in the news

Blogs on Measles cost-effectiveness of therapy

Directions to Hospitals Treating Measles

Risk calculators and risk factors for Measles cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]


Although there is still no specific antiviral treatment for measles, attending to the considerable decrease in morbidity and mortality of measles in the United States, with the introduction of measles vaccine, it may be considered that prevention of measles by vaccination shows cost-effectiveness.

Cost-Effectiveness of Therapy

Measles is a highly contagious disease caused by a virus, that if not prevented may have a noticeable impact on the population. Although there is still not a specific antiviral treatment for measles, proper vaccination as primary prevention may have noteworthy impact on its incidence. Evidence of such is the incidence of measles in the US population, before and after the introduction of the measles vaccine.[1]

  • Before the vaccine was introduced, almost all children got measles by the age of 15. At that time in the United States, about 450-500 people died every year, 48,000 were hospitalized, 7,000 had seizures and about 1,000 suffered permanent brain damage or deafness from measles.
  • Today, with the adequate access to vaccination, there are only about 60 cases a year reported in the United States. Of these, most have their origin outside of the US.

Considering the impact of vaccination in the incidence of measles, the costs may be justified by the benefit of vaccination.


  1. "Overview of Measles Disease".

Template:WikiDoc Sources